Fibrinopeptide A (FPA) BioAssay(TM) ELISA Kit (Human)

Product Overview

• Article Name: Fibrinopeptide A (FPA) BioAssay(TM) ELISA Kit (Human)
• Biozol Catalog Number: USB-025019
• Supplier Catalog Number: 025019
• Alternative Catalog Number: USB-025019-48,USB-025019-96
• Manufacturer: US Biological
• Category: Kits/Assays

Product Description

The Fibrinopeptide (FPA) ELISA Kit is a competitive inhibition immunoassay for the in vitro quantitative measurement of FPA in human serum, plasma, tissue homogenates, cell lysates, cell culture supernatants and other biological fluids. Detection Range: 1.23-100ng/ml Sensitivity: 0.55ng/ml Intra-Assay CV: <10% Inter-Assay CV: <12% Kit Components: *025019A: Microtiter Plate, 1x96 wells *025019B: Standard, 2x1 vial 025019C: Standard Diluent, 1x20ml *025019D: Detection Reagent A (green), 1x120ul *025019E: Detection Reagent B (red), 1x120ul 025019F: Assay Diluent A, 1x12ml 025019G: Assay Diluent B, 1x12ml 025019H: TMB Substrate, 1x9ml *025019J: Positive Control, 3.8ng/ml, 1x1vial (Lyophilized) 025019K: Stop Solution, 1x6ml 025019L: Wash Buffer, 30X, 1x20ml Precaution: The Stop Solution (025019K) suggested for use with this kit is an acid solution. Wear eye, hand, face, and clothing protection when using this material. Storage and Stability: Store *025019A, *025019B, *025019D, *025019E and *025019J at -20C. After reconstitution of *025019J, store at 4C and use within 5 days. Store all the other components at 4C. Unused kit is stable for 6 months after receipt. Once kit components are opened, it is highly recommended to use remaining reagents within 1 month provided this is within the expiration date of the kit. For maximum recovery of product, centrifuge the original vials after thawing and prior to removing the cap. Notes on 025019J: Positive Control: Intended Use: The positive control is from a human serum sample known to contain the target protein. It will provide a positive result in the ELISA assay, which indicates that the kit is optimized and working properly. Characteristics: The control vial contains human FPA in human serum (lyophilized powder). Note: The human based serum used in this product are screened for HIV, Hepatitis A, B, C, HTLV and Syphilis. Expected Values: 3.8ng/ml Usage: Dissolve with 150ul standard diluent and let stand for 10 minutes. If powder is partly insoluble, shake gently until fully dissolved. Mix gently before use. In the experiment, add 50ul to an appropriate well of the plate and test its concentration along with standards and your specimens. Note: Upon receipt store Positive Control vial at -20C. After reconstitution, store Positive Control vial at 4C and use within 5 days. Assay Procedure Summary: 1. Prepare all reagents, samples and standards. 2. Add 50ul standard or sample to each well, then add 50ul prepared Detection Reagent A immediately. Shake and mix. Incubate 1 hour at 37C. 3. Aspirate and wash 3 times. 4. Add 100ul prepared Detection Reagent B. Incubate 30 minutes at 37C. 5. Aspirate and wash 5 times. 6. Add 90ul Substrate Solution. Incubate 10-20 minutes at 37C. 7. Add 50ul Stop Solution. Read absorbance at 450nm immediately.